{"data":{"id":"us-in/ic-16-42-19-30","jurisdiction":"us-in","citation":"IC 16-42-19-30","heading":"Investigation of suspected legend drugs; records","body":"Sec. 30. (a) Sections 16 and 20 of this chapter do not apply to the actions of a:\n(1) person who is employed or retained as an investigator by a pharmaceutical manufacturer described in subdivision (3);\n(2) practitioner; or\n(3) pharmaceutical manufacturer that is approved by the federal Food and Drug Administration;\nperformed in an investigation of a pharmaceutical manufacturer's legend drug that is suspected of being counterfeited, adulterated, or misbranded.\n(b) A drug sample collected during an investigation described in subsection (a) may only be used for testing or a civil or criminal action. A drug sample collected during an investigation may not be resold or provided for human consumption.\n(c) A pharmaceutical manufacturer that collects drug samples during an investigation described in subsection (a) shall:\n(1) maintain records of the drug samples; and\n(2) make these records available, at a reasonable time, to law enforcement agencies or the agencies' representatives in the enforcement of this chapter.","path":["TITLE 16. HEALTH","ARTICLE 42. REGULATION OF FOOD, DRUGS, AND COSMETICS","Chapter 19. Drugs: Indiana Legend Drug Act"],"source_url":"https://iga.in.gov/ic/2026/Title_16.html#16-42-19-30","current_through":"2026","vintage":"2026","retrieved_at":"2026-09-11T20:02:18Z","sha256":"8684c9dc169a3113c8b3dddf9bbad0fd6d34a8fb89ff732f25a5ca93725204a4","source_id":"us-in","stale":false,"prev":"us-in/ic-16-42-19-29","next":"us-in/ic-16-42-20-1"},"notice":"GroundRules: Original legal text. Not legal advice."}